Your browser doesn't support javascript.
Slight reduction in SARS-CoV-2 exposure viral load due to masking results in a significant reduction in transmission with widespread implementation.
Goyal, Ashish; Reeves, Daniel B; Thakkar, Niket; Famulare, Mike; Cardozo-Ojeda, E Fabián; Mayer, Bryan T; Schiffer, Joshua T.
  • Goyal A; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, USA.
  • Reeves DB; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, USA.
  • Thakkar N; Institute for Disease Modeling, Global Health Division, Bill and Melinda Gates Foundation, Seattle, USA.
  • Famulare M; Institute for Disease Modeling, Global Health Division, Bill and Melinda Gates Foundation, Seattle, USA.
  • Cardozo-Ojeda EF; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, USA.
  • Mayer BT; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, USA.
  • Schiffer JT; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, USA. jschiffe@fredhutch.org.
Sci Rep ; 11(1): 11838, 2021 06 04.
Article in English | MEDLINE | ID: covidwho-1258600
ABSTRACT
Masks are a vital tool for limiting SARS-CoV-2 spread in the population. Here we utilize a mathematical model to assess the impact of masking on transmission within individual transmission pairs and at the population level. Our model quantitatively links mask efficacy to reductions in viral load and subsequent transmission risk. Our results reinforce that the use of masks by both a potential transmitter and exposed person substantially reduces the probability of successful transmission, even if masks only lower exposure viral load by ~ 50%. Slight increases in mask adherence and/or efficacy above current levels would reduce the effective reproductive number (Re) substantially below 1, particularly if implemented comprehensively in potential super-spreader environments. Our model predicts that moderately efficacious masks will also lower exposure viral load tenfold among people who get infected despite masking, potentially limiting infection severity. Because peak viral load tends to occur pre-symptomatically, we also identify that antiviral therapy targeting symptomatic individuals is unlikely to impact transmission risk. Instead, antiviral therapy would only lower Re if dosed as post-exposure prophylaxis and if given to ~ 50% of newly infected people within 3 days of an exposure. These results highlight the primacy of masking relative to other biomedical interventions under consideration for limiting the extent of the COVID-19 pandemic prior to widespread implementation of a vaccine. To confirm this prediction, we used a regression model of King County, Washington data and simulated the counterfactual scenario without mask wearing to estimate that in the absence of additional interventions, mask wearing decreased Re from 1.3-1.5 to ~ 1.0 between June and September 2020.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Viral Load / SARS-CoV-2 / COVID-19 / Masks Type of study: Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Sci Rep Year: 2021 Document Type: Article Affiliation country: S41598-021-91338-5

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Viral Load / SARS-CoV-2 / COVID-19 / Masks Type of study: Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Sci Rep Year: 2021 Document Type: Article Affiliation country: S41598-021-91338-5